ClearIt
Marblehead, US · Delaware corporation
Founders & leadership
ME
Martin E. SchmiegExecutive
JW
James Winkelman, M.DNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$4.4M disclosed across 6 rounds · 2018–2022
▶$25KraisedJul 2022 · 1 investors · BiotechnologyRule 506(b)
▶$25KraisedJul 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Martin E. SchmiegExecutive Officer, Director
- Gordon NyeDirector
- Offering amount
- $7M
- Amount sold
- $25K
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$300KraisedDec 2021 · 2 investors · BiotechnologyRule 506(b)
▶$300KraisedDec 2021 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gordon NyeDirector
- James Winkelman, M.D.Executive Officer, Director
- Martin E. SchmiegExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $300K
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$309.5KraisedMar 2021 · 18 investors · BiotechnologyRule 506(b)
▶$309.5KraisedMar 2021 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Martin E SchmiegExecutive Officer, Director
- James Winkelman, M.D.Executive Officer, Director
- Offering amount
- $309.5K
- Amount sold
- $309.5K
- First sale
- Dec 2020
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$500KraisedAug 2020 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedAug 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Martin E. SchmiegExecutive Officer, Director
- James Winkelman, M.DExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Aug 2020
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$2MraisedSep 2019 · 1 investors · BiotechnologyRule 506(b)
▶$2MraisedSep 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Martin E. SchmiegExecutive Officer, Director
- James Winkelman, M.D.Executive Officer, Director
- Offering amount
- $3M
- Amount sold
- $2M
- First sale
- Aug 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedOct 2018 · 14 investors · BiotechnologyRule 506(b)
▶$1.2MraisedOct 2018 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Martin E. SchmiegExecutive Officer, Director
- James W. Winkelman, M.D.Director
- Offering amount
- $1.4M
- Amount sold
- $1.2M
- First sale
- Oct 2018
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ClearIt raised?
- ClearIt has disclosed $4.4M raised across 6 rounds.
- Where is ClearIt headquartered?
- ClearIt is headquartered in Marblehead, US.